Pathstone Family Office, LLC Lantheus Holdings, Inc. Transaction History

Pathstone Family Office, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$48.76 - $77.67 $46,663 - $74,330	-957 Reduced 18.29%	4,274 $217,000
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $321,288 - $451,382	5,231 New	5,231 $368,000
Q1 2021 May 14, 2021	SELL	$13.77 - $21.66 $96 - $151	-7 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$11.98 - $16.34 $83 - $114	-7 Reduced 50.0%	7 $0
Q2 2020 Aug 14, 2020	BUY	$10.34 - $15.51 $144 - $217	14 New	14 $0

539

69.9M

651K

459K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.